This is NOT a big deal

This is NOT a big deal

Per a Roche press release;

“Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has signed an exclusive partnership agreement with Medtronic plc. Under the terms of the agreement, Roche will develop a dedicated Bluetooth Low Energy (BLE) enabled blood glucose monitoring meter that will communicate with Medtronic's future BLE enabled insulin pump systems. The new meter will be based on Roche's innovative Accu-Chek Guide platform and will be marketed under the name Accu-Chek Guide Link. The exclusive agreement covers all markets where future BLE enabled pumps will be commercialized . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.